Results 171 to 180 of about 38,997 (290)

Delayed-Onset Hypoglycemia After Levofloxacin Use in a Diabetic Patient. [PDF]

Case Rep Med
Dwaah H, Tupchong S, Kim J.
europepmc   +1 more source

Diabetes management in people undergoing metabolic‐bariatric surgery: A guideline from the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP) Group

Diabetic Medicine, Volume 43, Issue 5, May 2026.
Abstract The global prevalence of obesity and diabetes continues to rise, with metabolic‐bariatric surgery recognised as an effective intervention for obesity and type 2 diabetes, offering potential for type 2 diabetes remission and improved glycaemic control. This guideline, developed by the Joint British Diabetes Societies for Inpatient Care (JBDS‐IP)
Jeffrey W. Stephens, Ketan Dhatariya, Andrew J. Beamish, Dimitri J. Pournaras, Alexander D. Miras, Nader Raafat, Georgia Noble‐Bell, Rachel Cadwallader Buckland, Omar G. Mustafa   +8 more
wiley   +1 more source

Systematic review of oral carbohydrate treatment for hypoglycemia in people living with type 2 diabetes mellitus. [PDF]

BMC Endocr Disord
Prince N, Lochnan H, Shorr R, Garon-Mailer A, Sun CJ.   +4 more
europepmc   +1 more source

The role of membrane excitability in pancreatic β-cell glucotoxicity [PDF]

, 2019
Nichols, Colin G., Remedi, Maria S., Shyr, Zeenat A., Wang, Zhiyu, York, Nathaniel W.   +4 more
core   +1 more source

Real‐world treatment trajectories preceding GLP‐1 receptor agonist initiation in type 2 diabetes: A descriptive UK population‐based cohort study on adherence to national clinical guidelines

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3692-3702, May 2026.
Abstract Aims To investigate glucose‐lowering treatment trajectories preceding glucagon‐like peptide‐1 receptor agonist (GLP‐1RA) initiation in UK primary care, while assessing alignment with contemporary UK clinical guidelines, considering calendar time, cardiovascular disease (CVD) history, and obesity status.
Franziska S. Ulrich, Morten Frost Nielsen, Nicola Napoli, Andrea M. Burden   +3 more
wiley   +1 more source

Effectiveness of empagliflozin in reducing hypoglycemic events as compared to sulfonylurea in type 2 diabetes patients during fasting in Ramadan: a single-center study. [PDF]

BMC Endocr Disord
Kiran Z, Fatima N, Baloch AA, Shaikh KUS, Hasan SM, Khan MU.   +5 more
europepmc   +1 more source

Hepatic and abdominal adiposity in type 2 diabetes as assessed with machine learning on computed tomography scans

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3742-3751, May 2026.
Abstract Aims The combined assessment of multiple abdominal imaging traits in relation to type 2 diabetes remains incompletely characterised. The study examines these relationships on computed tomography (CT) scans from a large‐scale, racially diverse, disease‐focused medical biobank.
Richard H. Tran, Pavan Raghupathy, Mohamad Hazim, Elizabeth Thompson, Sophia Swago, Abhijit Bhattaru, Matthew MacLean, Jeffrey T. Duda, James Gee, Charles Kahn Jr., Daniel J. Rader, Arijitt Borthakur, Walter R. Witschey, Hersh Sagreiya   +13 more
wiley   +1 more source

Effect of antidiabetic medication adherence on risk of all-cause mortality and cardiovascular diseases in type 2 diabetes patients: Impact of antidiabetic adherence on cardiovascular disease. [PDF]

Medicine (Baltimore)
Seo DH, Ha KH, Kim SH, Kim DJ.
europepmc   +1 more source

Sodium‐glucose co‐transporter 2 inhibitors and obesity‐associated cancers in people with type 2 diabetes: A real‐world observational study

Diabetes, Obesity and Metabolism, Volume 28, Issue 5, Page 3807-3818, May 2026.
Abstract Aims To investigate the association between sodium‐glucose co‐transporter 2 inhibitors (SGLT‐2i) and obesity‐associated cancers (OAC) in individuals with type 2 diabetes (T2D). Materials and Methods This retrospective cohort study used data from the TriNetX US Collaborative Network.
Testimony Ipaye, Jonathan Goldney, Thomas Yates, Francesco Zaccardi, Kamlesh Khunti, Elina Akalestou, Melanie J. Davies, Karen Brown, Dimitris Papamargaritis   +8 more
wiley   +1 more source

Control of Kir channel gating by cytoplasmic domain interface interactions [PDF]

, 2017
Alekseev, Alekseev, Amorós, Antcliff, Bichet, Bushman, Bushman, Clarke, Colin G. Nichols, Drain, Dürr, Enkvetchakul, Enkvetchakul, Enkvetchakul, Eswar, Gloyn, Gribble, Hansen, Hibino, Hilgemann, Huang, Inagaki, Inagaki, Jiang, Koster, Koster, Kumar, Kuo, Kurata, Lederer, Lee, Lee, Lin, Lin, Lin, Linder, Loechner, Lopatin, Lopes, Loussouarn, Loussouarn, Lu, Martin, Nichols, Nichols, Nichols, Nichols, Proks, Proks, Qin, Qin, Qin, Qin, Remedi, Ribalet, Ribalet, Schwalbe, Shimomura, Shizhen Wang, Shyng, Shyng, Shyng, Shyng, Shyng, Shyng, Sievers, Sobolevsky, Sobolevsky, Suh, Sunjoo Lee, Tao, Trapp, Trapp, Whorton, William F. Borschel, Zhang, Zhu, Zubcevic   +77 more
core   +2 more sources